BioSpace News Archive

BioMidwest

AbbVie to Present at the Bank of America Merrill Lynch Healthcare Conference

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019

May 7, 2019
·
2 min read
Business

CPHI to Hold First Quarter 2019 Earnings Conference Call On Wednesday, May 15, 2019 at 8:30 a.m. ET

China Pharma Holdings, Inc. (“China Pharma”) (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its first quarter 2019 earnings conference call on Wednesday, May 15, 2019 at 8:30 a.m. ET.

May 7, 2019
·
1 min read
Business

Crescita Therapeutics Strengthens Leadership Team with New Vice-President in Aesthetic and Cosmeceutical Business Unit

Crescita Therapeutics Inc. is very pleased to announce that Mr. Jean Colas has joined Crescita as Vice-President of its Aesthetic and Cosmeceutical business unit.

May 7, 2019
·
2 min read
Drug Development

GenSight Biologics Announces Positive Data Safety Monitoring Board Review and Continuation of PIONEER Phase I/II Clinical Trial of GS030 Combining Gene Therapy and Optogenetics for the Treatment of Retinitis Pigmentosa

GenSight Biologics announced that the independent Data Safety Monitoring Board (DSMB) completed its first safety review of the ongoing PIONEER Phase I/II clinical trial of GS030 combining gene therapy and optogenetics for the treatment of Retinitis Pigmentosa.

May 7, 2019
·
6 min read
Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing

Proceeds will support ongoing clinical evaluation of HepaStem® in ACLF and launch of a clinical trial in late stage NASH set to commence in H1 2019 in Europe with significant further expansion into the US and Asia

May 7, 2019
·
3 min read
Deals

IRRAS Strengthens Position in Neurocritical Care by Acquiring Proprietary Assets, Including Four US FDA-cleared Products

Assets complement IRRAflow® and support positioning as a leading company in the space

May 7, 2019
·
3 min read
Business

IRRAS AB (PUBL) Interim Report January-March 2019

Focus on US - first sales in US reported early April and acquisition of complementary products in May

May 7, 2019
·
7 min read
Deals

IRRAS AB - Q1 Report 2019 - Invitation to Conference Call and Webcast

Tuesday May 7, at 04.00 p.m. CET IRRAS will host a conference call and an online presentation of its Q1 2019 interim report.

May 7, 2019
·
1 min read
Business

Half-year Figures: ZEISS Innovations Help Achieve Strong Growth

The ZEISS Group had a successful end to the first six months of fiscal year 2018/19 and saw its revenue rise by 9 percent to EUR 3.019 billion.

May 7, 2019
·
2 min read
Sweden’s First INSIGHT Installation Will Digitalize the Patient Flow

A pilot project, the first of its kind in Sweden, is currently underway in Region Värmland to connect Getinge’s digital patient flow system INSIGHT to Torsby Hospital, two clinics and two municipal businesses.

May 7, 2019
·
4 min read